Ipsen S.A. ADR (IPSEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IPSEY | CTLT | CERE | ||
| Company | Ipsen S.A. ADR | Catalent Inc | Cerevel Therapeutics Hldg Inc | ||
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | ||
| Open | 29.8900 | 58.00 | 42.74 | ||
| High | 29.8900 | 58.12 | 42.91 | ||
| Low | 29.8900 | 57.84 | 42.53 | ||
| Last | 29.8900 | 57.91 | 42.90 | ||
| Change | -0.4900 | -0.08 | +0.20 | ||
| % Change | -1.61% | -0.14% | +0.47% | ||
| Volume | 200 | 939,700 | 2,241,500 | ||
| 20-Day Average Volume | 740 | 1,899,800 | 2,664,650 | ||
| Previous Close | 30.3800 | 57.99 | 42.70 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 30.8297 | 57.03 | 41.15 | ||
| 20-Day Raw Stochastic | 24.30% | 84.90% | 95.65% | ||
| 20-Day Relative Strength | 45.71% | 63.11% | 59.72% | ||
| Weighted Alpha | -1.32 | +27.04 | +23.95 | ||
| Today's Opinion | 8% Sell | 88% Buy | 40% Buy | ||
| Previous Opinion | 24% Buy | 88% Buy | 40% Buy | ||
| Last Month's Opinion | 88% Buy | 16% Buy | 48% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.58% since 07/09/24 | +0.57% since 07/12/24 | +6.43% since 07/12/24 | ||
| Low | 29.5500 on 07/15/24 | 57.52 on 07/17/24 | 40.19 on 07/15/24 | ||
| High | 30.4950 on 07/15/24 | 58.23 on 07/17/24 | 43.10 on 07/18/24 | ||
| 1-Month | |||||
| %Chg | -8.87% since 06/18/24 | +5.16% since 06/18/24 | +2.51% since 06/18/24 | ||
| Low | 28.5800 on 07/09/24 | 54.55 on 06/20/24 | 38.50 on 06/25/24 | ||
| High | 31.0500 on 06/24/24 | 58.28 on 07/12/24 | 43.10 on 07/18/24 | ||
| 3-Month | |||||
| %Chg | +3.95% since 04/19/24 | +4.38% since 04/19/24 | +1.63% since 04/19/24 | ||
| Low | 28.5800 on 07/09/24 | 53.51 on 05/29/24 | 38.50 on 06/25/24 | ||
| High | 34.0600 on 05/24/24 | 58.28 on 07/12/24 | 43.10 on 07/18/24 | ||
| 6-Month | |||||
| %Chg | +4.36% since 01/19/24 | +17.68% since 01/19/24 | +1.54% since 01/19/24 | ||
| Low | 27.0000 on 02/13/24 | 48.78 on 01/23/24 | 38.50 on 06/25/24 | ||
| High | 34.0600 on 05/24/24 | 60.20 on 02/05/24 | 43.59 on 02/15/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,020,921 | 10,480,551 | 7,816,166 | ||
| Shares Outstanding, K | 335,260 | 180,980 | 182,195 | ||
| Annual Sales | 3,578,520,000 | 4,263,000,000 | 0 | ||
| Annual Net Income | 697,430,000 | -256,000,000 | -432,840,000 | ||
| Last Quarter Sales | N/A | 1,074,000,000 | 0 | ||
| Last Quarter Net Income | N/A | -101,000,000 | -131,910,000 | ||
| 60-Month Beta | 0.96 | 1.16 | 1.40 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.06 on 05/08/24 | -0.73 on 05/08/24 | ||
| Latest Earnings Date | 02/08/24 | 09/03/24 | 08/07/24 | ||
| Most Recent Dividend | 0.212 on 05/31/24 | N/A | N/A | ||
| Next Ex-Dividends Date | 05/31/24 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||